# Asclemed USA Inc. dba Enovachem Pharmaceuticals – FDA Inspection, Sep 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/6f1a6e9b-11cc-426d-aea3-aaa665e9f2a9
Source feed: FDA_Inspections

> FDA inspection 1067059 of Asclemed USA Inc. dba Enovachem Pharmaceuticals, September 27, 2018. Classification: Official Action Indicated (OAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067059
- Company Name: Asclemed USA Inc. dba Enovachem Pharmaceuticals
- Inspection Date: 2018-09-27
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1263548 - 2025-03-05
- FDA Inspection 1111700 - 2019-11-05
- [FDA Inspection 1029155 - 2017-10-12](https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/7f4c0a1a-1fbe-487e-99f1-159e81ab9865)
- FDA Inspection 937934 - 2015-07-15
- FDA Inspection 828037 - 2013-04-18

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/rumany-c-penn/021eb1e0-8de0-403f-9596-3e76624b2e5a)
- Issuing Officer

Company: https://www.keypedia.com/companies/asclemed-usa-inc-dba-enovachem-pharmaceuticals/4accbf56-7f89-4c0a-8196-1290061fb20e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
